TKIs can induce vascular endothelial damage, hypertension and myocardial injury by acting on the targets VEGFR, platelet-derived growth factor receptor (PDGFR) and stem cell factor receptor (SCFR). The gene discussed is KDR; the disease is hypertensive disorder.